Originally published April 16, 2008 at 12:00 AM | Page modified June 30, 2008 at 2:10 PM
Corrected version
Pathway Medical raises $24.5 million for plaque device
Pathway Medical Technologies said Tuesday that it has raised $24.5 million in venture capital from existing investors — money geared...
Seattle Times business reporter
Pathway Medical Technologies said Tuesday that it has raised $24.5 million in venture capital from existing investors — money geared to help the firm launch its first commercial product later this year.
The latest cash influx brings the total raised by the Kirkland-based medical-device maker to about $80 million, Chief Executive Tom Clement said. The company's newly padded war chest should last it until revenue starts coming in from sales of its system for clearing out arterial plaque.
"We shouldn't need another round of investment in the next year and a half, if that," Clement said.
Pathway seeks to market a device to treat peripheral-arterial disease by sending a catheter with rotating blades up an artery to bore through accumulated fat and vacuum the debris away.
The device, under review by the U.S. Food and Drug Administration, is to be used in patients' legs to improve circulation and prevent amputations. It could be an alternative to surgery and other methods, which include widening blood vessels and costly laser catheters that burn plaque away.
Pathway's main rival is Fox Hollow, of Redwood City, Calif., which sells the SilverHawk, a catheter to remove plaque from peripheral arteries.
Boston Scientific markets a similar product, called the Rotablator, for the treatment of coronary arterial disease. That device was developed by Redmond-based Heart Technology, which the Massachusetts company later acquired.
The fresh infusion of cash is the latest act in Pathway's revival. The company briefly shut down in late 2004 when it ran out of money. But Clement, a Heart Technology veteran who helped develop the Rotablator, persuaded investors to give the company a new start.
Confident that the market will embrace Pathway's product, the venture backers behind the previous financings — HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and other individual investors — didn't want anybody else admitted to the latest funding round, Clement said.
"They asked that we did the round internally," he said.
Pathway has some 100 employees. After receiving FDA approval, expected in the third quarter, the company intends to expand as it creates a sales and marketing team, but Clement declined to say how many jobs would be created.
Local medical-device companies have been enjoying venture capital's favor lately. Last month, Redmond-based Spiration raised $18.5 million from existing investors to fund the launch of a catheter-like technology to treat severe emphysema.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Material from The Seattle Times archives is included in this story.
Information in this article, originally published April 16, 2008, was corrected June 30, 2008. A previous version of this story incorrectly stated that Pathway Medical Technologies' chief executive is Tom Clements. His name was misspelled.
Copyright © 2008 The Seattle Times Company
UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case
UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip
UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award
UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall
NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook

general classifieds
Garage & estate salesFurniture & home furnishings
Electronics
just listed
2007 Ranger Z20 Comanche
2009 Polaris Ranger 700 EFI 4x4
Award Winning Designer Furniture Sale - Gar...
More listings
POST A FREE LISTING
- Agency set to investigate handling of 911 call about Josh Powell
- Proposal to link Market, aquarium may be too ambitious for Seattle
- Chilling 911 tapes reveal pleas for help to go to Josh Powell home
- UW's Shawn Kemp Jr. makes own way despite familiar name, number | Steve Kelley
- State Medicaid to quit paying for ER visits deemed unnecessary
- NBA's David Stern open to league returning to Seattle
- Prosecutor: Powell's final act ends doubt he killed wife
- Was idea of court-ordered test too much for Josh Powell?
- Local aerospace suppliers say they feel squeezed by Boeing
- California gay-marriage ruling may affect Washington
- Gay-marriage bill passes House, awaits Gregoire's signature
331 - Sheriff's office unhappy with 911 dispatcher in caseworker's call
221 - Romney's bad day is Santorum's best in GOP race
188 - Gay-marriage ruling may affect Washington or Prop. 8 ruling could reach into Washington
170 - State Medicaid program to stop paying for unneeded ER visits
167 - Dicks channeled federal money to Puget Sound project his son ran
124 - 3 big health insurers stockpile $2.4 billion as rates keep rising
115 - Study shows link between payroll and wins not as big as before, but teams like Mariners still face bigger obstacles than others
89 - Historic day for gay marriage as another fight looming
79 - Video --- UW offensive coordinator/quarterbacks coach Eric Kiesau
71
- State Medicaid to quit paying for ER visits deemed unnecessary
- Here it is: The secret to stir-fried chicken | Taste
- Local aerospace suppliers say they feel squeezed by Boeing
- Dicks channeled federal money to Puget Sound project his son ran
- Buttoned Up: Nine immutable laws of time management
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Happy Hour: French-accented charm at Gainsbourg
- 'Gauguin and Polynesia': dazzling mix-and-match | Art review
- Gay-marriage bill passes House, awaits Gregoire's signature
- Agency set to investigate handling of 911 call about Josh Powell
